Borsani Oscar, Varettoni Marzia, Riccaboni Giacomo, Rumi Elisa
Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Department of Hematology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.
Front Med (Lausanne). 2024 Aug 12;11:1419092. doi: 10.3389/fmed.2024.1419092. eCollection 2024.
Erythrocytosis is one of the most common abnormalities that clinical hematologists, general practitioners, and internal medicine specialists could have to face off in their routine clinical practice. While diagnostic criteria for primary erythrocytosis (i.e., polycythemia vera) are well known and characterized, there are several causes of secondary erythrocytosis that should be kept in mind to avoid misdiagnosis. Congenital heart defects are rarely cause of secondary erythrocytosis as they are normally recognized and treated at an early stage. Eisenmenger syndrome is a complex clinical syndrome that arise as consequence of an untreated congenital heart defect associated with large intracardiac shunt. The clinical picture of this syndrome usually includes a severe erythrocytosis that could tempt clinicians to start an intensive phlebotomy (or venesection) program. However, clinicians should be aware that erythrocytosis in Eisenmenger syndrome is a compensatory mechanism aimed at improving blood oxygen-carrying capacity; accordingly, phlebotomies should be reserved for those cases complaining hyperviscosity symptoms. Here we present a case of an adult female patient with Eisenmenger syndrome that has been evaluated because of severe and persistent erythrocytosis. In this case we present a step-by-step approach by which clinical hematologist could proceed to reach the definitive diagnosis. We will also provide some hints that could help clinicians when choosing the best treatment strategy to avoid unnecessary and potentially harmful procedures.
红细胞增多症是临床血液科医生、全科医生和内科专家在日常临床实践中可能不得不面对的最常见异常情况之一。虽然原发性红细胞增多症(即真性红细胞增多症)的诊断标准已广为人知且有明确特征,但继发性红细胞增多症的病因有多种,应牢记于心以避免误诊。先天性心脏病很少是继发性红细胞增多症的病因,因为它们通常在早期就会被识别和治疗。艾森曼格综合征是一种复杂的临床综合征,是由未治疗的先天性心脏病伴大的心脏内分流引起的。该综合征的临床表现通常包括严重的红细胞增多症,这可能会促使临床医生启动强化放血(或静脉切开术)方案。然而,临床医生应意识到,艾森曼格综合征中的红细胞增多症是一种旨在提高血液携氧能力的代偿机制;因此,放血疗法应仅用于那些有高黏滞症状的病例。在此,我们报告一例因严重且持续性红细胞增多症而接受评估的成年女性艾森曼格综合征患者。在这个病例中,我们展示了临床血液科医生可逐步进行以达成明确诊断的方法。我们还将提供一些提示,可帮助临床医生在选择最佳治疗策略时避免不必要且可能有害的程序。